SCHEMBL31489207

SCHEMBL31489207

Cc1ccc(C)n1-c1nc2cc(-c3cncc(-c4cn[nH]c4)n3)ccn2n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 5/20 0.33
PIK3CG P48736 5/20 0.33
PIK3CD O00329 4/20 0.31
PDE10A Q9Y233 2/20 0.31
ROCK2 O75116 5/20 0.31
PIM1 P11309 1/20 0.30
PIM3 Q86V86 1/20 0.30
PIM2 Q9P1W9 1/20 0.30
CD38 P28907 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HTT P42858 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
MET P08581 1/20 0.30
PAK4 O96013 1/20 0.30
JAK1 P23458 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CB P42338 1/20 0.30
CSNK1A1 P48729 1/20 0.30
AAK1 Q2M2I8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489506 0.91 ROCK2 (0.34) MAPK1PIK3CGPDE10AROCK2KDM4E
SCHEMBL31489351 0.82 ROCK2 (0.35) PIK3CGPIK3CDROCK2PIK3CA
SCHEMBL31489910 0.81 CYP11B2 (0.37) MAPK1PIK3CGPIK3CDPDE10AKDM4E
SCHEMBL31489906 0.75 CREBBP (0.31)
SCHEMBL31489311 0.75 CREBBP (0.31)
SCHEMBL31489179 0.71 KDM4E (0.35) MAPK1PDE10AKDM4EALDH1A1HTT
SCHEMBL31489399 0.71 KDM4E (0.35) MAPK1PDE10AKDM4EALDH1A1HTT
SCHEMBL25675424 0.69 PIK3CG (0.52) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL25646778 0.69 JAK2 (0.38) PIK3CGPIK3CDROCK2PIM1PIM3
SCHEMBL31489689 0.67 AHR (0.50) MAPK1PDE10AROCK2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed